NETZERO360

EnvoMed 80,On-Site Medical Waste Treatment

Shred, sterilize, and recycle medical waste on-site in 18 minutes. No transportation. No incineration. No landfill. The first waste-to-virgin-plastic recycling system deployed in the United States.

0L

Capacity Per Cycle

0 min

Treatment Time

0%

Volume Reduction

Level IV

STAATT Sterilization

How It Works

Four Steps From Infectious Waste to Virgin Plastic

Step 1

Load

Biohazardous waste,sharps, syringes, PPE, bandages, containers,is loaded directly into the EnvoMed 80 on-site. No external pickup. No transit. No chain-of-custody handoffs.

Step 2

Shred

A 4-shaft industrial shredder reduces all waste to small, unrecognizable fragments. Patient privacy is preserved. Every item is destroyed beyond identification in seconds.

Step 3

Sterilize

Biocetic 45,peracetic acid and hydrogen peroxide at 1% concentration,achieves STAATT Level IV sterilization: 99.9999% kill rate of bacterial spores in solid and liquid phases. No heat. No steam. No emissions.

Step 4

Recycle

Sterilized plastic fragments are sorted by resin type using BAC's proprietary work instructions, then sent to domestic processors to become virgin-grade plastic pellets. The loop is closed.

The Full-Cycle Difference

Every other program stops at sterilization. We stop at circularity.

Most medical waste companies shred and sterilize, then throw the output in a dumpster. The infectious risk is gone, but millions of pounds of perfectly good plastic still end up in a landfill. That is not sustainability. That is disposal with extra steps.

NETZERO360 closes the loop completely: medical waste is shredded, sterilized to STAATT Level IV, sorted by resin type, and sent to domestic recycling processors who convert it into virgin-grade plastic pellets. Those pellets re-enter the manufacturing supply chain as raw material for new products.

This is what a circular economy looks like in healthcare waste management. Not carbon credits. Not offsets. Not estimates. Physical material flowing from infectious medical waste back into the manufacturing supply chain,tracked with chain-of-custody documentation at every step.

Shred + Sterilize

EnvoMed 80 destroys and disinfects on-site. STAATT Level IV. 18 minutes.

Sort by Resin Type

BAC's proprietary work instructions separate HDPE, LDPE, PP, PET, and other resins.

Recycle to Virgin Grade

Sorted resin streams go to domestic processors. Output: virgin-grade plastic pellets.

New Products

Pellets re-enter the supply chain. Medical waste becomes raw material. Loop closed.

BAC orchestrates the entire chain. That is NETZERO360.

What It Treats

Biohazardous Waste Streams

The EnvoMed 80 handles the full spectrum of regulated biohazardous medical waste generated by healthcare facilities.

Sharps (needles, scalpel blades, lancets)
Syringes (with or without needles)
Plastic sharps containers (red bins)
Bandages, dressings, wound care materials
Gloves, masks, gowns, and PPE
Dialysis filters and tubing
Contaminated medical instruments
Blood, urine, and stool samples
Human tissue specimens
IV bags and tubing

Not treated by EnvoMed 80

Pharmaceutical chemicals, cytotoxic/chemotherapy waste, radioactive materials, large hard metal surgical instruments, and titanium items. BAC maintains separate compliant pathways for each of these waste streams.

Technology Specs

EnvoMed 80 Specifications

ParameterSpecification
Capacity80 liters per cycle
Cycle Time15-18 minutes
SterilizationSTAATT Level IV (6 LOG10)
Volume Reduction80-90%
DisinfectantBiocetic 45 (peracetic acid + H2O2, 1%)
Solid OutputNon-infectious shredded material, recyclable
Liquid OutputWater, oxygen, acetic acid,safe for sewage
Room Requirements3 x 5m, ventilated
InfrastructureElectricity, water, pressurized air, drainage
NoiseLow (enclosed shredder)
OdorNone
EmissionsNone

Validated Results

Proven in the World’s Most Demanding Environments

HUS Helsinki University Hospital

Finland's largest academic medical center deployed the EnvoMed system and reported 30% cost savings over off-site treatment. High-volume clinical validation in a demanding regulatory environment.

Takeda Climate Solutions Prize (2024)

Takeda's BioLife plasma centers (230+ locations) challenged startups to solve single-use plastic waste. EnvoMed won. A global pharmaceutical company selected this technology over every alternative.

South Korea Regulatory Approval

The EnvoMed system cleared the full regulatory pathway in South Korea, demonstrating international compliance across diverse healthcare regulatory frameworks.

BAC Fairfield, CA,First US Deployment

Installed at BayArea Compliance's Fairfield facility in early 2026. Mike Tufu and Terrell Puckett trained on-site by the manufacturer for one full week. The first operation in the US to integrate EnvoMed into a complete waste-to-virgin-plastic recycling program.

On-site treatment and NETZERO360 circularity led by Lisa Puckett ,CSP, 2025 NRC Recycler of the Year, SWANA Vice Director, Founding Executive Director of NETZERO360 Sustainable Waste Solutions

Frequently Asked Questions

EnvoMed 80 and On-Site Treatment

The EnvoMed 80 achieves STAATT Level IV sterilization, the highest standard recognized by CDPH for alternative medical waste treatment technologies. California's Medical Waste Management Act (HSC Section 117960) requires CDPH-approved treatment methods. The system's Level IV performance exceeds the minimum Level III threshold for CDPH alternative treatment approval.

STAATT (State and Territorial Association on Alternate Treatment Technologies) Level IV is the highest sterilization standard, requiring 6 LOG10 (99.9999%) reduction of bacterial spores in both solid and liquid phases. Most autoclaves achieve Level III. The EnvoMed 80 achieves Level IV,killing a broader range of organisms more completely than standard centralized treatment.

The EnvoMed 80 does not treat pharmaceutical chemicals, cytotoxic or chemotherapy waste, radioactive materials, large hard metal surgical instruments, or titanium items. These require separate handling under RCRA, NRC, or DEA regulations. BAC maintains compliant pathways for all of these streams as part of our full-service compliance programs.

For biohazardous waste, yes. Waste treated on-site is rendered non-infectious and can be disposed of as regular municipal solid waste. You would still need permitted haulers for pharmaceutical waste, chemotherapy waste, radioactive materials, and pathological waste requiring incineration. BAC manages all of these streams.

Yes. The plastics are sterilized to Level IV, shredded to uniform particle size, and sorted by resin type using BAC's proprietary work instructions. Domestic recycling processors convert sorted single-resin streams into pellets meeting virgin-grade specifications. The key is proper sorting,unsorted mixed plastic cannot reach virgin grade, but properly sorted sterilized streams can.

On-site treatment with recycling integration improves every sustainability metric: waste diversion rate increases (recycled instead of landfilled), Scope 3 transportation emissions drop to zero for the treated stream, and you gain documented circular economy outcomes with full chain-of-custody verification. All data flows into your NETZERO360 dashboard, ready for SB 253, SB 261, and investor-facing ESG reports.

See On-Site Treatment in Action

Request a free waste analysis and learn how the EnvoMed 80 and NETZERO360 can transform your facility's medical waste from a pure cost into a sustainability asset.

833-247-OSHAGet My Quote